Search results
Greenwood Capital Associates LLC Purchases 2,576 Shares of Vertex Pharmaceuticals Incorporated...
ETF DAILY NEWS· 6 days agoGreenwood Capital Associates LLC boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 11.3% in the fourth ...
Brokerages Set Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) PT at $438.48
ETF DAILY NEWS· 5 days agoVertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) has been given an average rating of “Moderate Buy” by the twenty-five research firms ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Fisher Asset Management LLC
ETF DAILY NEWS· 3 days agoFisher Asset Management LLC raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.3% in the fourth quarter, according ...
Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades' - NVIDIA...
Benzinga· 6 days agoOn CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex Pharmaceuticals...
Teachers Retirement System of The State of Kentucky Decreases Holdings in Vertex Pharmaceuticals...
ETF DAILY NEWS· 7 days agoTeachers Retirement System of The State of Kentucky reduced its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 18.9% during ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 days agoIn terms of fundamental and technical metrics, the best biotech stocks trading above 10 right now...
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
TipRanks via Yahoo Finance· 3 days agoDespite my optimism about the long-term prospects of curative gene therapy and CRISPR Therapeutics...
‘Life-changing’ cystic fibrosis drugs to be made available on NHS
Press Association News via AOL· 3 days agoMore than 11,000 people in the UK have the condition. John Stewart, NHS England director of...
Stocks Show Signs of Buyer Exhaustion After Rally: Markets Wrap
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Stocks retreated after a rally to all-time highs spurred calls for a near-term...
Equities Research Analysts’ Price Target Changes for June 17th (ACN, AMAT, AMH, ARM, ASML, AVB,...
ETF DAILY NEWS· 6 days agoEquities Research Analysts’ price target changes for Monday, June 17th: Accenture (NYSE:ACN) had its...